Examkin

Question

Difficulty: HardGynecologic Oncology

A 4848-year-old multiparous woman presents to the clinic complaining of heavy, irregular vaginal bleeding, foul-smelling discharge, and deep pelvic pain for the past 33 months. She has not seen a physician in over a decade. Pelvic examination reveals a 66-cm friable, exophytic mass replacing the cervix. Rectovaginal examination demonstrates nodularity and induration extending into the medial aspect of the right parametrium, but not to the pelvic sidewall. Arrange the following steps in the most appropriate sequence for the diagnosis, staging, and definitive management of this patient's condition.

  1. 1Perform an office-based punch biopsy of the friable cervical lesion
  2. 2Obtain a whole-body PET/CT scan for radiologic staging
  3. 3Initiate definitive external beam radiation therapy with concurrent cisplatin
  4. 4Administer intracavitary brachytherapy to the primary tumor site
  5. 5Commence long-term clinical surveillance and symptom monitoring

Answer

The optimal sequence is: Cervical biopsy, followed by PET/CT staging, external beam radiation with concurrent chemotherapy, intracavitary brachytherapy, and finally long-term clinical surveillance.
The patient's presentation of a large cervical mass with parametrial involvement is highly suspicious for locally advanced cervical cancer (Clinical Stage IIB). The initial step is always to secure a tissue diagnosis via biopsy of the visible lesion. Once confirmed, clinical staging with advanced imaging (PET/CT) is required to evaluate nodal status and distant spread. Because the disease extends into the parametrium, primary surgery is contraindicated. Definitive management consists of concurrent chemoradiation therapy, which typically involves whole-pelvic external beam radiation paired with cisplatin, followed by localized intracavitary brachytherapy to maximize tumor destruction. Finally, patients enter a strict post-treatment clinical surveillance program.

Step-by-Step Solution

1
Diagnose via tissue biopsy
Histologically confirms invasive cervical carcinoma.
All oncologic treatment pathways require definitive tissue confirmation prior to extensive radiologic staging or intervention.
2
Stage via advanced imaging (PET/CT)
Evaluates the extent of disease, specifically focusing on pelvic and para-aortic lymph node spread and distant metastasis.
Clinical examination identified parametrial involvement (Stage IIB). Radiologic staging is necessary to define the required radiation treatment fields.
3
Treat with external beam radiation and chemotherapy (EBRT + Cisplatin)
Provides targeted regional therapy with systemic radiosensitization.
Parametrial involvement makes the patient a poor candidate for primary surgical resection (radical hysterectomy). Concurrent chemoradiation is the definitive standard of care.
4
Boost therapy with brachytherapy
Delivers a maximum, targeted radiation dose to the primary tumor bed.
Supplementing external beam radiation with intracavitary brachytherapy improves local control rates while sparing adjacent healthy pelvic organs (bladder and rectum).
5
Perform ongoing clinical surveillance
Monitors the patient for clinical remission, treatment complications, or disease recurrence.
Regular follow-up detects early signs of recurrent disease that might be amenable to targeted salvage therapies (e.g., pelvic exenteration).

Key Concept

The diagnostic and management pathway for locally advanced cervical cancer (Stage IB3 and higher) requires establishing a tissue diagnosis, radiologic staging via PET/CT, and definitive chemoradiation therapy rather than primary surgical resection.
Rate this question

Topics

Gynecologic Oncology

More questions from this topic